Tevogen Non Current Assets Total vs Cash And Short Term Investments Analysis
| TVGNW Stock | 0.06 0 5.66% |
Tevogen Bio financial indicator trend analysis is much more than just breaking down Tevogen Bio Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tevogen Bio Holdings is a good investment. Please check the relationship between Tevogen Bio Non Current Assets Total and its Cash And Short Term Investments accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Non Current Assets Total vs Cash And Short Term Investments
Non Current Assets Total vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tevogen Bio Holdings Non Current Assets Total account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Tevogen Bio's Non Current Assets Total and Cash And Short Term Investments is -0.58. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Tevogen Bio Holdings, assuming nothing else is changed. The correlation between historical values of Tevogen Bio's Non Current Assets Total and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Tevogen Bio Holdings are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Current Assets Total i.e., Tevogen Bio's Non Current Assets Total and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | -0.58 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Tevogen Bio Holdings balance sheet. This account contains Tevogen Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Tevogen Bio Holdings fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Tevogen Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tevogen Bio Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Tevogen Bio's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to about 10.2 K in 2024, whereas Selling General Administrative is likely to drop slightly above 1.8 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 9.4K | 230.8K | 265.4K | 278.7K | Total Operating Expenses | 4.6M | 953.1K | 2.3M | 2.1M |
Tevogen Bio fundamental ratios Correlations
Click cells to compare fundamentals
Tevogen Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.